CAMBRIDGE, Mass., July 21 /PRNewswire/ -- Cytel Inc., a leading provider of clinical trial design software and services, announced that it has named John Hallinan as Chief Financial Officer. Mr. Hallinan will oversee all finance and administration functions and play a key role in corporate development.
Hallinan is a certified public accountant and brings extensive financial and management experience to Cytel, along with extensive knowledge of the software industry and life sciences. Hallinan served as Chief Financial Officer of CambridgeSoft Corporation, the leading supplier of software and enterprise solutions to the pharmaceutical and biotech industry, and most recently as Chief Financial Officer at Signet Laboratories, a privately-held supplier of diagnostic assays to the pharmaceutical and biotech industry. Hallinan has more than twenty years of experience in positions of increasing responsibility across a broad range of disciplines, including technology licensing, venture financings, and mergers and acquisitions.
This new position charges Hallinan to establish financial and administrative systems and policies to support Cytel’s development and revenue goals. “I greatly look forward to having John join the Cytel management team,” said Ranganath Nayak, Cytel’s Chief Executive Officer. “With his help, we will strengthen our financial, customer relationship, and human resources management. His experience in technology licensing and mergers & acquisitions will also be a valuable asset for Cytel as we further expand our offerings.”
About Cytel Inc.
Cytel Inc. has an 18-year track record as the premier provider of software and services for the design and analysis of clinical trials. Cytel provides software, training, and consulting to clinical trial sponsors seeking to run their trials more efficiently. Cytel’s East software is used by every division of the FDA and by hundreds of biostatisticians and clinicians in industry and academia to design, simulate and monitor group sequential and adaptive flexible clinical trials. More than 10,000 customers also use Cytel’s award-winning StatXact(R) and LogXact(R) software for exact statistical inference. Cytel Inc. is a privately owned company, headquartered in Cambridge, Massachusetts, and with software development operations in Pune, India. Major investors in Cytel include its founders and Merck Capital ventures.
Contact: Mike Weitz 617 528-7132
Cytel Inc.
CONTACT: Mike Weitz of Cytel Inc., +1-617-528-7132
Web site: http://www.cytel.com//
